(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States...
Stats | |
---|---|
本日の出来高 | 18.53M |
平均出来高 | 5.48M |
時価総額 | 203.07M |
EPS | $0 ( 2024-05-01 ) |
次の収益日 | ( $-3.65 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.260 |
ATR14 | $0.0200 (0.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-07 | Glessner Coleen | Sell | 585 | Common Stock |
2024-04-07 | Hartzel William | Sell | 665 | Common Stock |
2024-03-13 | Papa Joseph C | Buy | 750 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Williams Paul Anthony | Buy | 125 000 | Employee Stock Options (Right to Buy) |
2024-03-13 | Glessner Coleen | Buy | 125 000 | Employee Stock Options (Right to Buy) |
INSIDER POWER |
---|
95.71 |
Last 100 transactions |
Buy: 2 920 145 | Sell: 69 613 |
ボリューム 相関
Emergent BioSolutions Inc 相関
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Emergent BioSolutions Inc 相関 - 通貨/商品
Emergent BioSolutions Inc 財務諸表
Annual | 2023 |
収益: | $1.05B |
総利益: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2023 |
収益: | $1.05B |
総利益: | $292.50M (27.88 %) |
EPS: | $-14.85 |
FY | 2022 |
収益: | $1.12B |
総利益: | $427.20M (38.11 %) |
EPS: | $-4.47 |
FY | 2021 |
収益: | $1.79B |
総利益: | $1.04B (57.75 %) |
EPS: | $4.32 |
Financial Reports:
No articles found.
Emergent BioSolutions Inc
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。